Scanning Microscopy
Volume 8

Number 2

Article 15

5-4-1994

Intercellular Interactions in PC12 Cells Overexpressing Beta/A4
Amyloid
Gladys E. Maestre
Harvard Medical School

Barbara A. Tate
Brown University

Ronald E. Majocha
Brown University

John Maguire
McMaster University, Ontario

Charles A. Marotta
Brown University

Follow this and additional works at: https://digitalcommons.usu.edu/microscopy
Part of the Biology Commons

Recommended Citation
Maestre, Gladys E.; Tate, Barbara A.; Majocha, Ronald E.; Maguire, John; and Marotta, Charles A. (1994)
"Intercellular Interactions in PC12 Cells Overexpressing Beta/A4 Amyloid," Scanning Microscopy: Vol. 8 :
No. 2 , Article 15.
Available at: https://digitalcommons.usu.edu/microscopy/vol8/iss2/15

This Article is brought to you for free and open access by
the Western Dairy Center at DigitalCommons@USU. It
has been accepted for inclusion in Scanning Microscopy
by an authorized administrator of DigitalCommons@USU.
For more information, please contact
digitalcommons@usu.edu.

Scanning Microscopy, Vol. 8, No. 2, 1994 (Pages 325-336)
Scanning Microscopy International, Chicago (AMF O'Hare), IL 60666 USA

0891-7035/94$5.00

+ .25

INTERCELLULAR INTERACTIONS IN PC12 CELLS
OVEREXPRESSING BETA/A4 AMYLOID
Gladys E. Maestre 1'•, Barbara A. Tate2, Ronald E. Majocha 2 •4 , John Maguire3, and Charles A. Marotta 2 •4
1Department

of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA 02115

2Dept. Psychiatry and Human Behavior, and 4Dept. Neuroscience, Brown University, Providence, RI 02912
3Dept. Pathology, Hamilton General Hospital, and McMaster Univ. Medical Centre, Ontario Canada

(Received for publication November 30, 1993 and in revised form May 4, 1994)
Introduction

Abstract

Alzheimer's disease (AD) is the most common of
the dementing illnesses leading to impaired intellectual,
occupational and social performance (Katzman, 1986).
It is the most common form of adult-onset dementia and
is the fourth leading cause of death in the United States
(Hay and Ernst, 1987). Among the neuropathological
changes found in the brain, high concentrations of senile
plaques containing (3 amyloid are observed in cerebral
cortex, subcortical structures, and cerebellum. (3 amyloid is composed of fibrils of 4-8 nm diameter. The
protein forms the cores of plaques and is found in congophilic angiopathy of Alzheimer brain (G Jenner et al.,
1981; Masters et al., 1985).
Beta amyloid is a peptide of approximately 4 kDa
derived from a much larger glycoprotein, the amyloid
precursor protein (APP) (Dyrks et al., 1988; Esch et
al., 1990; Kang et al., 1987). The latter exists in multiple transmembrane forms (APP 695 , APP 751 , APP770)
that result from alternative splicing of primary transcripts of a single precursor gene (Kitaguchi et al.,
1988). Fragments of APP containing the (3 amyloid
peptide have been found in normal brains (Ghiso et al.,
1992) and cerebrospinal fluid (Palmert et al., 1990),
suggesting that (3 amyloid has a normal but unknown
role. Determination of the function of the (3 amyloid
peptide may help to clarify the mechanism of formation
and the consequences of amyloid deposition that occurs
specifically in the AD brain.
There is evidence to suggest that APP plays a role
in cell-cell and cell-matrix interactions (Breen et al.,
1991; Chen and Yankner 1991; de Sauvage and Octave,
1989; Dyrks et al., 1988; Klier et al., 1990; Shivers et
al., 1988; Ueda et al., 1989). This putative function appears to be due, at least in part, to an amino acid sequence located within the (3 amyloid peptide (Chen and
Yankner, 1991; Ghiso et al., 1992). However, it is not
known how (3 amyloid is related to the organization of
cellular and membranous molecules that are responsible
for maintenance of the cellular matrix and intercellular
junctions.

The amyloid precursor protein (APP) is an integral
membrane component of eukaryotic cells. A variety of
research approaches have addressed the contribution of
the (3 amyloid peptide region of the APP to neuritic
plaque structure and formation in the Alzheimer disease
brain as well as the relationship between (3 amyloid accumulation and the occurrence of dementia. However,
there is limited information available concerning the
cellular consequences of amyloid deposition. The present studies were undertaken to investigate the relationship between (3 amyloid and intercellular junctions.
Transfected PC12 cell lines, that overexpress the (3 amyloid peptide, exhibit structural and functional alterations
at the cell surface and tend to form aggregates more
readily than normal control cells. Intermediate junctions
were the most common intercellular interactions of both
normal and transfected cells. However, the control and
transfected cells differed since areas of continuous and
extensive junctions were readily seen in transfected cells
and infrequently seen in control cells. The data suggest
that excess accumulation of (3 amyloid is associated with
the junctional apparatus and may be related to increased
intercellular adhesion.
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Interactions between cells may influence their viability and functional roles within tissues (Bissell and Barcellos-Hoff, 1978; Farmer et al., 1978; Singer, 1992;
Vasiliev, 1985). Changes in inter-neuronal associations,
the relationships between neurons and other cell types,
and their relationship to the microenvironment are implicated in brain aging (Vemadakis, 1985). Modifications
in membranous structures including synaptic and nonsynaptic junctions (Terry et al., 1991), which may require cell adhesion molecules, may be prerequisites for
the acquisition of memory (Bailey and Kandel, 1993).
The role, if any, of the transmembrane amyloid precursor protein and the f3amyloid peptide in modulating
cellular interactions is unknown.
To begin to explore the relationship between f3amyloid and cell-cell interactions, we examined the morphological consequences of overexpressing the human
(3 amyloid-C-terminal peptide in rat pheochromocytoma
(PC12) cells (Maestre et al., 1992a,b, 1993; Majocha et
al., 1993; Tate et al., 1991). PC12 cells were permanently transfected with human amyloid precursor protein
(APP) DNA that codes for 97 amino acids. These represent 40 f3amyloid residues followed by the remainder
of the C-terminal region of the APP (Marotta et al.,
I 989).
In the present work, the cells were characterized by
light (LM) and transmission electron microscopy (TEM)
with immuno-staining. By these approaches, we determined whether or not contacts established by cells that
overexpress f3amyloid were uniquely different from
those formed by control cells.

that included the A4 sequence and the flanking regions
(Zain et al., 1988). The Min vector constructs were
used for insertion of the EcoRI digested amy37 cDNA
fragment into the three translational reading frames.
Vectors were digested
with EcoRI
restnct10n
endonuclease, to cleave at the unique EcoRI site, and
with alkaline phosphatase.
The lambda gtll-amy37
chimera (Zain et al., 1988) was digested with EcoRI
enzyme, and the 1.1 kb long fragment, containing the
A4 site, was isolated. The 1.1 kb fragment was ligated
into the Min vectors by established techniques.
The
amy37-l. l kb chimeric plasmids generated separately in
the three reading frames were propagated; the DNA was
isolated, purified, and used for transfection experiments
(see below). Sequence analyses were carried out as
described elsewhere (Zain et al., 1988).
Earlier
transfections were applied to COS-I, CV-1, HS683, SKN-SH and Al72 cell lines. The cells used in the present
studies were PC12 cells, derived from rat adrenal
pheochromocytoma obtained from Dr. ltzak Fisher
(Medical College of Pennsylvania, Philadelphia).
Permanent transfection experiments were conducted
using the general procedures of van der Eb and Graham
(1980). Integration of the 1.1 kb amyloid cDNA insert
was carried out as described above except that the transfection medium contained 10 µg of vectors with amy37l. l inserts. Controls consisted of vector DNA without
an amyloid cDNA insert. Five µg PSV 2 CAT DNA (the
chloramphenicol acetyltransferase gene cloned into an
SV 40 based plasmid), and 5 µg of Pko + Neo plasmid
DNA (in an SV 40 based plasmid) was used. The latter
carried the gene for Neomycin resistance that was sensitive to Geneticin.
CAT (chloramphenicol acetyl
transferase) assays to assess transfection efficiency were
carried out according to Gorman et al. (1982). The
various transfectants were selected for survival in the
presence of Geneticin (G418, GIBCO) at a concentration
of 0.4 gm/I for 6 days, and then at 0.3 gm/I for 3 days;
the cells were subsequently maintained at 0.2 gm/I. The
cells shown in accompanying figures had undergone at
least 20 cell divisions. Integration and expression of the
DNA insert was confirmed by southern, northern, and
western blot analyses in addition to immunocytochemical
staining with anti-(3 amyloid monoclonal antibodies
(Mabs) (Maestre et al., 1992a; Tate et al., 1992).

Materials and Methods
Preparation of transfected cells
The initial cloning vehicle was an SV40-based vector, Pko + RI/ML, composed of PMLi, a derivative of
PBR322 (lacking certain prokaryotic sequences poisonous for eukaryotic cell replication), the Lac UV 5 promotor of E. coli, and SV 40 sequences covering the enhancer, origin of replication, early promotor, t/T antigen
splice sites and polyadenylation sites. Modification of
the initial vector was carried out to produce three variants, Min + I, + 2 and + 3, with three different translational reading frames utilizing the ATG codon of the T/t
antigen (Marotta et al., 1989). The starting vector or
modified forms were used for experimentation.
The
precursor to the Min series contained a unique Pvull site
(enhancer start) and a Barn HI site (poly A addition
site), both of which were modified to Xbal sites by
standard techniques.
From an AD brain complementary DNA (cDNA)
expression vector library prepared with bacteriophage
lambda, we obtained an insert, referred to as amy37,

Methodology for cell preparation and fixation
Cells were grown in 35 mm plastic plates. For
Coomassie blue staining, cells were prefixed in Hanks
buffered saline with 5 mM EGT A/well and 200 µl 2 %
glutaraldehyde was added to fix the cells overnight. The
cells were subssequently rinsed with 10 % methanol
(MeOH) for two minutes, 20 % MeOH for two minutes,
326
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Figure l. Light microscopy of control and (3 amyloid positive PC12 cells stained with Coomassie brilliant blue demonstrating the tendency to form aggregates. (A) Normal control (NN) cells. (B) Vector transfected control (V120) cells
lacking a (3 amyloid insert. (C) (3 amyloid positive transfected AC126 cells. (D) (3 amyloid positive transfected AC127
cells. Bar = 50 J-lm.

and then stained with 0.1 % Coomassie blue in 20 %
MeOH for two minutes and 1 % acetic acid for 20 minutes. For destaining, the cells were rinsed with 20%
MeOH plus 1 % acetic acid for two minutes. The cells
were finally rinsed twice in 1 % acetic acid.
Cells were fixed with 2 % paraformaldehyde, 2.5 %
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for
30 minutes, postfixed with OsO 4 for 30 minutes, dehydrated through graded ethanols, and embedded in Epon
on cover-slipped glass slides. The plates were rinsed
briefly with Hank's salt solution and fixed with fresh 4%
paraformaldehyde in 0.13 M NaCl, 0.02 M phosphate
buffer, pH 7.4 (phosphate buffered saline, PBS) for 30
minutes at room temperature. They were rinsed 3 times

with PBS for 10 minutes each time. Thin sections (60
nm) were cut using an ultramicrotome and placed on
grids which were then examined with a JEOL 1200 EX
transmission electron microscope.

Transmission electron
chemical study

microscopy

immunocyto-

After the cells reached a confluence of approximately 75 %, the plates were rinsed with Hank's salt solution
and fixed with 4% paraformaldehyde in 0.13 M NaCl,
0.02 M phosphate buffer, pH 7.4 (PBS) for 30 minutes
at room temperature. They were rinsed 3 times with
PBS. Cells were immunostained with Mabs (IgG) prepared against a synthetic polypeptide with the (3 amyloid
sequence as reported by Masters et al. (1985). As
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were uniquely different from those formed by control
cells. At the ultrastructural level, the transfected AC126
and AC127 cells demonstrated more extensive areas of
intercellular contact than in the non-transfected control
cells. The diverse intercellular junctions were analyzed
and subclassified into the following categories:

shown elsewhere (Majocha et al., 1988), the Mabs were
highly specific for {3 amyloid. Primary antibody supernatants were diluted 1:5 in ANP buffer (2 % bovine
serum albumin, 0.3 M NaCl, 0.02 M phosphate, pH
7.2) containing 0.01 % Triton X-100. Incubation was
overnight at 4 °C. The following day, cells were washed
3 times (for 10 minutes each) with buffer containing 0.3
M NaCl and 20 mM Tris, followed by 2 hour incubation
with 5 µglml of biotinylated goat anti-mouse lgG
[Jackson lmmunoresearch in buffer (without detergent)].
Cells were washed as before. They were then incubated
with
strepavidin-horseradish-peroxidase
conjugate
(Sigma) at 0.25 µglml in ANP buffer (without detergent)
for 2 hours and washed as above. The chromogen used
was diaminobenzidine (Sigma) 0.5 mg/ml, imidazole
(Sigma) 1 mg/ml, in 100 mM Tris, pH 7.0. Hydrogen
peroxide was added just before use at 0.015 % (1 µl of
30% H 20 2/2 ml). The reaction was allowed to proceed
for 2 minutes at room temperature followed by two
rinses with distilled water. The cells were then postfixed in 2 % glutaraldehyde. Identification of cellular
junctions was according to established procedures
(Ghadially, 1988; Quinonez and Simon, 1988).

Intermediate junctions. The most commonly observed junctions were of the intermediate type (Figs. 2C
and 2D). They displayed some variability in appearance: in extended areas of intercellular contact, extensive
intermediate type junctions were observed. This type of
junction was more commonly observed in transfected
cells as compared to control cells. The majority were
characterized by paired subplasmalemmal densities that
were up to 30 nm thick. The inter-membrane thickness
was approximately 25 nm. Occasional subplasmalernmal
densities were associated with an increased concentration
of adjacent cytoplasmic intermediate filaments. The filaments were frequently organized in a parallel plane to
the plasma membrane without a well developed perpendicular arrangement. Shorter less extensive intermediate
type junctions were also identified. This type of intermediate junction appeared to be more readily observable
in control cells than in transfected cells. Occasionally,
this junctional type formed the only points of contact between control cells. Infrequent intermediate junctions
demonstrated a better developed perpendicular arrangement of intermediate filaments and, therefore, more
closely resembled desmosomes. Well formed desmosomes were not identified in either control (Figs. 2A and
2B) or transfected cells (Figs. 2C and 2D).

Staining of actin
Control and {3 amyloid-positive transfected cell lines
were grown as above for 48 hours on glass slides coated
with poly(L-lysine) and fixed with 4 % paraformaldehyde
for 5 minutes. The cells were incubated at room temperature for 30 minutes in Hank's solution containing 1
µM rhodamine-phalloidin. The cells were then postfixed with 4 % paraformaldehyde for 10 minutes; the
slides were rinsed and coverslipped. Photographs were
taken using an inverted microscope (Bio Star) equipped
with a 35 mm camera and epifluorescence optics.

Hemi-subplasmalemmaljunctions. Very occasional hemi-cell junctions were observed in PC12 cells in the
absence of cell contact (Fig. 3A). These were characterized by areas of increased subplasmalemmal density
without an associated perpendicular arrangement of intermediate filaments to the cell membranes. In some instances, an intercellular space between cells displaying
these junctions contained a fine granular material of unknown nature. The intercellular distances at junctions
were wide and measured approximately 100 nm. At
these points, subplasmalemmal densities were observed.
In the present study, the hemi-subplasmalemma junctions
were not observed in amyloid-positive transfectants,
however, they may be present to a minor extent relative
to control levels.

Results
Light microscopy
The {3 amyloid positive transfectants (AC126 and
AC127), when compared to normal control cells (NN)
cells that were transformed by the transfecting vector
minus the {3 amyloid DNA (V120) plated at the same
concentration, tended to form aggregates (Figure 1).
The current experiment confirmed an earlier observation
(Tate et al., 1992). The AC126 and AC127 transfectants displayed a more cohesive arrangement in culture
and the points of intercellular contact were therefore
more extensive and numerous than in control cells
(Figure 1).

Tight junctions. Both transfected and non-transfected control cells showed occasional points of very
close intercellular approximation of cell membranes.
They appeared as a series of focal connections between
membranes of adjacent cells. These structures were interpreted as resembling tight junctions (Fig. 3B). On the
material examined, no gap junctions were identified.

Transmission electron microscopy (TEM)
TEM was performed to determine whether or not
contacts established by cells that overexpress {3 amyloid
328
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Figure 2. Transmission electron micrographs demonstrating
intermediate
Junctions.
(A) Normal control
(NN) cells.
(B)
Vector transfected control (V120)
cells
lacking
a
(3 amyloid insert.

(C) (3 amyloid positive
transfected
AC127 cells.
(D) (3 amyloid positive
transfected
AC127 cells.

In areas of extended
intercellular contact,
intermediate
type
junctions were well
formed. There is a
corresponding organized arrangement of
microfilaments, intermediate
filaments,
and microtubules in
the underlying cellular cytoplasm.
The
intermediate filaments
and microtubules are
oriented parallel to
the cellular membrane.
Bars = 200 nm.
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Figure 3. Transmission electron micrographs demonstrating a tight junction and hemi-subplasmalemmal junction. (A)
(3 amyloid positive transfected AC127 cells showing a tight junction. (B) NN normal control PC12 cells showing hemisubplasmalemmal densities. Bars = 100 nm.

fJamyloid epitope at contact sites

allel arrangement of intermediate filaments in the subplasmalemrnal region was occasionally associated with
membranous imrnunostaining for (3 amyloid.

The possible relationship between the accumulation
of the (3 amyloid peptide and intercellular contact sites
was assessed by imrnunocytochemistry and studied with
TEM in both (3 amyloid-positive transfectants (Figs. 4B
and 4C) and in control cells (Fig. 4A). The areas of
imrnunostaining for the (3 amyloid epitope corresponded
to the areas of extended intercellular contact (Figs. 4B
and 4C). This pattern of imrnunostaining was not observed in control cells (Fig. 4A). A corresponding par-

To demonstrate that the immunostain label was the
result of specific (3 amyloid accumulation, an unrelated
control MAB, anti-ribonuclease inhibitor protein (RIP)
(Majocha et al., 1987), was used for comparative analysis. Even though identical procedures were employed,
the anti-RIP MAB did not deposit on membranes or
intercellular spaces (Maestre et al., 1992a).
330
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Figure 4. Transmission electron m.icrographs of immuno-stained control and f3amyloid positive transfected PC12 cells
using monoclonal antibodies to the /3peptide region of the APP. (A) Normal control (NN) cells. (B) f3amyloid
positive transfected AC126 cells. (C) f3amyloid positive transfected AC127 cells. In B and C, immuno-positive
material is present in appreciable quantities at the intercellular junctions. Bar = 640 nm.

Distribution of actin. Cells were stained with phalloidin-rhodamine and studied at the LM level. As suggested by the TEM observations, actin accumulated subapically in linear bundles that coursed parallel to the
edge of the /3amyloid-positive cell types (Figs. SC and
SD). By contrast, in control cells actin was more concentrated at the tip of neurites (Figs. SA and SB). When
two adjacent control cells were observed, little or no
accumulation of actin was observable (Figs. SA and SB).

Discussion
Transfected PC12 cell lines that overexpress the

f3amyloid peptide exhibit structural and functional
alterations at the cellular surface.
We previously
reported that these cells display increased numbers of the
membrane elaborations, including m.icrovilli and blebs
(Maestre et al., 1992a), enhanced ruffling activity
(Maestre et al., 1993), and modified cell-substrate adhesion properties (Maestre et al., 1992b). Here, we report
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Figure 5. Fluorescence microscopy of control and /3amyloid positive PC12 cells stained with phalloidin-rhodamine
to demonstrate the redistribution of immunofluorescent actin fibers after transfection with /3amyloid DNA. (A) No.rmal
control (NN) cells. (B) Vector transfected control (V120) cells lacking a /3amyloid insert. (C) /3amyloid positive
transfected AC127 cells photographed to emphasize the intercellular junctions. (D) /3amyloid positive transfected
AC127 cells photographed to emphasize the intracellular distribution of actin fibers. Bar = 70 µm.

---------------------------------------------------------------------------------------------that intercellular contact is also affected in /3amyloid
positive cells. The cells have a greater tendency to form
aggregates than do normal control. PC12 cells or PC12
cells transfected with a vector lacking the /3amyloid-Cterminal insert. Increased electron density was found at
the junctional membrane sites of transfected cells overexpressing /3amyloid.

The more commonly observed type of junction that
mediates clustering in the /3amyloid positive aggregates
is the intermediate junction. Although intermediate type
junctions were also seen in control cells, the occurrence
of continuous and extensive intermediate type junctions
was common in transfected cells that overexpressed
amyloid. However, tight junctions and hemi-subplasma-
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lemma! densities were also noted. Intercellular structures resembling tight junctions, but not gap junctions,
were found in control and {3 amyloid-positive transfected
cells. Freeze etching techniques could be employed to
make a more definitive identification of the tight junctions and to conclusively exclude the occurrence of gap
junctions.
There are multiple determinants that influence the
type of junction that can form. These include environmental cues and tissue distribution (Chiu et al., 1992);
regeneration (Gluck et al., 1992); and the stage of development (Duband and Thiery, 1990). Junctions are
also influenced by rearrangements of cytoskeletal components such as the accumulation of actin bundles at the
cytoplasmic surface of the plasma membrane (Volberg
et al., 1986). Current investigations are aimed at
identifying neuronal markers, including cytoskeletal
constituents, that may be perturbed by overaccumulation
of the {3 amyloid peptide. In a concurrent study, we
observed that {3 amyloid-positive transfectants exhibited
reduced levels of neurofilaments and synaptophysin
(Majocha et al., 1992).
Neither the role of the {3 amyloid peptide in the
formation of specific junctional types, nor the consequences of this process for intercellular communication,
if any, are currently understood. However, certain relevant observations can be cited. In the transfected PC12
cells, the {3 amyloid-C terminal region of the APP that
is overexpressed includes the transmembrane domain
(Marotta et al., 1989). The {3 amyloid antigen colocalizes with the membrane (Maestre et al., 1993); and from
in vitro studies, it is known that the {3 peptide has a
strong tendency to self-aggregate (Gorevic et al., 1987;
Halverson et al., 1990; Honda and Marotta, 1992;
Kirschner et al., 1987). Based on these observations,
we can hypothesize that overexpression of the {3 amyloid
peptide enhances the ability of the cell to form symmetrical junctions directly or indirectly. A direct role may
include homotypic binding among {3 amyloid peptides at
the surface of two cells; or, heterotypic binding may occur which would include the interaction between {3 ?myloid amino acids and a receptor or ligand on another
cell. It is possible that the observed effects are due to
a non-{3-amyloid region of the overexpressed protein.
Indeed, although {3 amyloid peptide has been shown to
be toxic in some circumstances, it has also been reported
that other regions of the c-terminal fragment not involving the amyloid region can also be toxic to PC12 cells
(Kozlowski et al., 1992). Therefore, additional studies
are necessary to confirm that the observations reported
here are due to {3 amyloid peptide alone.
Structural changes that underlie the acquisition of
memory support the notion that synaptic growth occurs
at the expense of non-synaptic junctions (for review, see

Bailey and Kandel, 1993). Deficits in memory are a
clinical hallmark of AD, and this impairment may be directly related to the compromised integrity of intemeuronal interactions. We provided evidence that excess accumulation of {3 amyloid C-terminal peptide is related to
increased intercellular adhesion and that the peptide is
associated with the intercellular junctional apparatus.
The {3 amyloid peptide may compromise membrane integrity (Arispe et al., 1993; Nitch et al., 1992) and mediate membrane turnover at these sites. This suggested
process would interfere with dynamic neuronal connectivity and synaptic growth. To some extent this proposed mechanism may be reflected by the differences in
actin distribution we observed in {3 amyloid positive cells
compared with controls.
Thus, among the consequences of the suggested
processes may be memory impairment. Alterations in
intercellular interactions in the AD brain have not been
directly explored to a notable extent. Genetically engineered PC12 cells transfected with the C-terminal region
of APP DNA provide important opportunities to analyze
intercellular alterations that are directly associated with
the accumulation of the {3 amyloid peptide. These studies will extend our understanding of cellular mechanisms
associated with {3 amyloid that contribute to the dementia
of AD.
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Discussion with Reviewers

F.N. Low: The author's interpretations of cell junctions, particularly in the transmission electron micrographs, would not be approved by critical cell biologists
(although not necessarily wrong). For example, in Figure 3A, the tight junction does not show pentalaminar
organization. This may be because it is cut diagonally
in a section too thick for satisfactory identification. .
Authors: Prof. Low justifiably addresses the difficulties
in confirming tight junctions in this material. For the
purpose of clarification, a tight junction was defined as
follows: "A tight junction consists of a series of punctuate contacts in which the dense outer leaflets of adjoining membranes converge and fuse to form a single line.
Often, the outer dense line of the outer membrane is interrupted at the sites of membrane fusion. The width of
diffused membranes is slightly less than the combined
width of the two unit membranes" (Quinonez and
Simon, 1988). Prof. Low's comments concerning the
thickness of the section are appreciated. In fact, as
mentioned in text, freeze-fracturing techniques could be
employed to better study gap junctions and tight junctions; these techniques were not utilized in this study.
Based upon the limitations of the techniques that we
used in our study, the example of tight junction presented in this paper should still be acceptable considering the
above cited definition for this type of junction.

335

G.E. Maestre et al.

G.D. Miner: What is the relative importance of {3 amyloid to the basic causes of Alzheimer's Disease considering the chromosome 14AD gene, the chromosome 19
(APO-E4) gene, the chromosome 21 ("FAD") gene, and
the yet to be discovered chromosome location of the
Volga-German early onset FAD?
Authors: The relative importance of 13amyloid in the
pathogenesis of AD is unknown. The current view is
that AD is a heterogeneous syndrome, from both a clinical and a genetic point of view. The fact that mutations
in the APP gene (chromosome 21) are sufficient to cause
AD has been the major argument in favor of amyloid as
an active participant in the events that lead to degeneration in the brains of AD victims. In addition, even
though linkage of AD and chromosome 14 and 19 have
been reported, the mechanisms for which these loci
could be pathogenic are uncertain. In the case of the
Apoliproprotein E gene (ApoE) on chromosome 19, precise definition as an AD susceptibility gene or as a gene
in linkage disequilibrium with the "true AD gene" is
necessary. However, in families with APP mutations,
the e-4 genotypes predispose to earlier onset, which
suggest that ApoE could be a "modifier" instead of a
determinant factor in the pathogenic pathway leading to
AD [Alzheimer's Disease Collaborative Group (1993).
Apolipoprotein E genotype and Alzheimer's disease.
Lancet 342: 737-738; and St. George-Hyslop P, Crapper
McLachlan D, Tuda T, Rogaev E, Karlinsky H, Lippa
CF, Pollen D ( 1994). Alzheimer's disease and possible
gene interaction. Science 263: 537).

G.D. Miner: Are there any specific and differing (i.e.,
variant) functions or purposes of the three transmembrane forms of APP (e.g., APP 695 , APP 751 and APP 770 )
known? Are there any important reasons for these multiple forms, or is it a redundancy built into the biochemical genetic system?
Authors: The expression of the amyloid precursor protein (APP) gene is highest (all forms) during neurological development. The dominant form in the brain is the
695 isoform, whose expression has previously been
found to be largely restricted to the central nervous
system. During neonatal development in the rat basal
forebrain, the ratio between isoform 695 and other
Kunitz containing APP's is the highest. The precise
function of APP during development, or at any other
time for that matter, is not known [Sherman CA,
Higgins GA (1992). Regulated splicing of the amyloid
precursor protein gene during postnatal development of
the rat basal forebrain. Brain Res Dev Brain Res 6: 6369).
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